Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where VISTAGEN THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-03-31: from running the business, $66.44M went out.
  • Fiscal year ended 2026-03-31: from investing, $877.00K went out.
  • Fiscal year ended 2026-03-31: from financing, $30.97M came in.
  • Fiscal year ended 2026-03-31: change in cash, $36.34M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2026-03-31-$66.44M-$877.00K$30.97M*-$36.34M
2025-03-31-$42.10M-$13.15M$3.21M*-$52.03M
2024-03-31-$25.81M-$61.00K$128.40M*$102.53M
2023-03-31-$49.72M-$740.00K-$1.04M*-$51.50M
2022-03-31-$45.26M-$200.40K$10.48M*-$34.97M
2021-03-31-$12.07M-$275.40K$12.96M$101.14M*$101.75M
2020-03-31-$15.76M$0.00$3.35M$662.80K*-$11.75M
2019-03-31-$14.53M-$174.00K$17.04M$2.72M
2018-03-31-$9.06M-$1.60K$16.72M$7.46M
2017-03-31-$7.26M-$239.10K$9.90M$2.49M
2016-03-31-$4.81M-$26.30K$280.00K$4.91M*$358.50K
2015-03-31-$2.77M$3.15M$70.00K
2014-03-31-$2.13M$9.60K$250.00K$1.08M-$638.10K
2013-03-31-$3.46M-$135.40K$3.22M$1.19M$557.10K
2012-03-31-$3.57M-$32.40K$2.68M$860.70K*-$58.30K
2011-03-31-$841.30K-$57.80K$837.40K*-$61.70K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2026-06-30-$14.71M$0.00$928.00K-$13.80M
2026-03-31-$16.20M*-$99.00K*
2025-12-31-$17.63M*$104.00K*$2.31M*
2025-09-30-$13.76M*-$94.00K*$27.93M*
2025-06-30-$18.85M-$788.00K$397.00K$1.09M*-$18.15M
2025-03-31-$10.06M*$527.00K*$1.95M*
2024-12-31-$10.28M*-$422.00K*$1.06M*
2024-09-30-$10.89M*-$7.79M*$0.00*
2024-06-30-$10.87M-$5.47M$0.00-$16.25M
2024-03-31-$6.99M*-$29.00K*
2023-12-31-$4.75M*-$32.00K*$210.00K*$93.52M*
2023-09-30-$6.19M*$0.00*$34.96M*-$785.00K*
2023-06-30-$7.89M$0.00$1.07M-$7.02M
2023-03-31-$7.47M*-$528.00K*$0.00*
2022-12-31-$9.93M*-$12.50K*
2022-09-30-$16.34M*-$24.40K*
2022-06-30-$15.97M-$175.10K-$16.15M
2022-03-31-$15.59M*-$100.00*
2021-12-31-$12.05M*$100.00*$2.12M*
2021-09-30-$11.45M*-$50.50K*$7.35M*
2021-06-30-$6.17M-$149.90K$44.50K$946.90K*-$5.33M
2021-03-31-$5.28M*-$25.50K*-$17.10K*$4.10M*-$1.22M*
2020-12-31-$4.99M*-$151.10K*$13.60K*$94.06M*$88.93M*
2020-09-30$1.00M*-$98.80K*$12.90M*$13.85M*
2020-06-30-$2.81M$0.00$62.60K$2.93M*$190.80K
2020-03-31-$2.58M*$0.00*$2.70M*$291.80K*
2019-12-31-$4.28M*$0.00*$650.00K*$620.50K*-$3.01M*
2019-09-30-$4.14M*$0.00*$0.00*-$4.22M*
2019-06-30-$4.76M$0.00$0.00-$4.80M
2019-03-31-$3.56M*-$4.20K*$10.43M*$6.82M*
2018-12-31-$3.91M*$0.00*$1.83M*$530.90K*-$1.55M*
2018-09-30-$3.93M*-$134.40K*$4.72M*$600.40K*
2018-06-30-$3.14M-$35.40K$57.50K-$3.15M
2018-03-31-$2.60M*$0.00*$400.00*-$2.65M*
2017-12-31-$2.44M*$0.00*$13.77M*$11.27M*
2017-09-30-$1.88M*-$1.60K*$2.07M*$136.20K*
2017-06-30-$2.13M$0.00$873.30K-$1.29M
2017-03-31-$229.20K*-$1.45M*
2016-12-31-$2.10M*-$2.20K*$247.90K*-$1.89M*
2016-09-30-$2.20M*-$5.70K*$0.00*-$2.24M*
2016-06-30-$1.67M-$2.00K$9.54M$8.07M
2016-03-31-$21.70K*-$729.90K*
2015-12-31-$1.17M*-$4.60K*$0.00*$1.64M*$464.40K*
2015-09-30-$1.51M*$0.00*$0.00*$2.08M*$573.00K*
2015-06-30-$823.30K$0.00$280.00K$594.30K*$51.00K
2015-03-31-$894.50K*$1.02M*$56.80K*
2014-12-31-$341.00K*$398.00K*
2014-09-30-$521.60K*$210.20K*
2014-06-30-$1.01M$1.52M$400.70K
2014-03-31-$467.10K*$19.20K*$0.00*$477.60K*-$20.70K*
2013-12-31-$342.50K*$24.10K*$330.60K*$14.20K*
2013-09-30-$584.60K*-$24.10K*$210.30K*-$83.30K*
2013-06-30-$731.80K-$9.60K$57.00K-$548.30K
2013-03-31-$970.00K*-$4.30K*$1.00M*$704.50K*$613.90K*
2012-12-31-$962.60K*$310.60K*$793.90K*$10.80K*
2012-09-30-$1.23M*$1.22M*-$18.30K*
2012-06-30-$296.20K-$49.30K
2012-03-31-$718.60K*-$19.00K*$150.80K*$501.40K*-$85.40K*
2011-12-31-$1.06M*-$5.60K*$311.20K*$824.80K*$71.90K*
2011-09-30-$702.20K*$0.00*-$847.50K*
2011-06-30-$1.09M$2.22M$802.70K
2011-03-31-$90.42K*-$46.00*-$140.11K*
2010-12-31$17.67K*-$52.29K*$0.00*-$165.18K*
2010-09-30-$443.23K*$0.00*$790.35K*$347.12K*
2010-06-30-$325.32K-$5.46K-$103.53K

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B